Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART-123 (thrombomodulin alfa) in sepsis with disseminated intravascular coagulation
2007-002035-81Phase 2Completed
- Sponsor
- Artisan Pharma
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sepsis and disseminated intravascular coagulation (DIC) comparing ART-123 with Placebo (2 arms). Primary endpoint: 28-day all-cause mortality. Started Jun 2007; status: completed.
02
Drugs
thrombomodulin alfa
03
Conditions
sepsisdisseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on 2007-002035-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002035-81.